DeepMed Research

Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

rTMS for Relieving Chronic OA Pain

Not Applicable

Withdrawn

Conditions: Chronic Pain
Osteo Arthritis Knee

Interventions: Device: Transcranial Magnetic Stimulation

First Posted Date: 2021-10-28

Last Posted Date: 2023-02-03

Lead Sponsor: Northwestern University

Registration Number: NCT05097729

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Olfactory Decision-making and Deprived Sleep

Not Applicable

Completed

Conditions: Sleep Deprivation

Interventions: Behavioral: Sleep deprivation

First Posted Date: 2021-10-26

Last Posted Date: 2022-07-13

Lead Sponsor: Northwestern University

Target Recruit Count: 46

Registration Number: NCT05093413

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian Cancer

Not Applicable

Completed

Conditions: Neoadjuvant Chemotherapy
Prehabilitation
Ovarian Cancer

Interventions: Behavioral: Healthy Lifestyle Control
Behavioral: FIT4SURGERY

First Posted Date: 2021-10-26

Last Posted Date: 2025-04-29

Lead Sponsor: Northwestern University

Target Recruit Count: 30

Registration Number: NCT05092763

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer

Phase 1

Withdrawn

Conditions: Breast Inflammatory Carcinoma
Prognostic Stage IV Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Triple-Negative Breast Carcinoma

Interventions: Drug: Carboplatin
Biological: Pembrolizumab
Genetic: Transferrin Receptor-Targeted Liposomal p53 cDNA

First Posted Date: 2021-10-26

Last Posted Date: 2022-11-15

Lead Sponsor: Northwestern University

Registration Number: NCT05093387

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Immune Response to SARS-CoV-2/COVID-19 Vaccination in Sarcoidosis

Completed

Conditions: Sarcoidosis
SARS-CoV2 Infection
Vaccine Response Impaired

Interventions: Diagnostic Test: Assay of (1) the level of anti-spike IgG antibody, and (2) interferon-gamma release in response to SARS-CoV-2 antigen stimulation

First Posted Date: 2021-10-22

Last Posted Date: 2023-02-01

Lead Sponsor: Northwestern University

Target Recruit Count: 101

Registration Number: NCT05089565

Locations: 🇺🇸
Northwestern Medicine, Chicago, Illinois, United States

MRI-Guided High-Definition Transcranial Direct Current Stimulation (tDCS) for Depression

Not Applicable

Completed

Conditions: Depression

Interventions: Device: Transcranial Direct Current Stimulation
Device: Sham Transcranial Direct Current Stimulation

First Posted Date: 2021-10-22

Last Posted Date: 2025-04-27

Lead Sponsor: Northwestern University

Target Recruit Count: 26

Registration Number: NCT05090397

Locations: 🇺🇸
CTI Northwestern, Chicago, Illinois, United States

Novel Non-opioid Post-surgical Pain Treatment in Females

Phase 2

Withdrawn

Conditions: Acute Pain
Toe Fusion
Bunionectomy

Interventions: Drug: Naproxen

First Posted Date: 2021-10-21

Last Posted Date: 2024-03-18

Lead Sponsor: Northwestern University

Registration Number: NCT05087914

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

Imaging of Retinochoroidal Vasculature in Patients Being Assessed for Cardiovascular Disease

Not Applicable

Recruiting

Conditions: Cardiovascular Diseases
Retina; Change

Interventions: Diagnostic Test: Swept Source Optical Coherence Tomography Angiography

First Posted Date: 2021-10-19

Last Posted Date: 2024-03-22

Lead Sponsor: Northwestern University

Target Recruit Count: 50

Registration Number: NCT05082402

Locations: 🇺🇸
Northwestern University/Northwestern Medical Group, Department of Ophthalmology, Chicago, Illinois, United States

Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP)

Phase 4

Completed

Conditions: Kidney Calculi
Urologic Diseases
Benign Prostatic Hypertrophy

Interventions: Drug: Tranexamic acid

First Posted Date: 2021-10-18

Last Posted Date: 2024-05-16

Lead Sponsor: Northwestern University

Target Recruit Count: 110

Registration Number: NCT05082142

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus

Not Applicable

Recruiting

Conditions: Esophageal Cancer
Barrett Esophagus

Interventions: Device: WATS-3D tissue sampling following forceps biopsies
Device: WATS-3D tissue sampling prior to forceps biopsies

First Posted Date: 2021-09-24

Last Posted Date: 2024-04-24

Lead Sponsor: Northwestern University

Target Recruit Count: 200

Registration Number: NCT05056051

Locations: 🇺🇸
University of California, LA, Los Angeles, California, United States
🇺🇸
Washington University in St. Louis, Barnes Jewish Hospital, Saint Louis, Missouri, United States
🇺🇸
University of Colorado, Aurora, Colorado, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy